Acumen Pharmaceuticals, Inc. (ABOS)

Acumen Pharmaceuticals Statistics

Total Valuation

ABOS has a market cap or net worth of $82.38 million. The enterprise value is -$57.02 million.

Market Cap	82.38M
Enterprise Value	-57.02M

Important Dates

The last earnings date was Tuesday, August 12, 2025, before market open.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

ABOS has 60.57 million shares outstanding. The number of shares has increased by 3.87% in one year.

Current Share Class	60.57M
Shares Outstanding	60.57M
Shares Change (YoY)	+3.87%
Shares Change (QoQ)	+0.08%
Owned by Insiders (%)	15.11%
Owned by Institutions (%)	32.63%
Float	32.93M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.68
P/TBV Ratio	0.68
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.97, with a Debt / Equity ratio of 0.26.

Current Ratio	5.97
Quick Ratio	5.79
Debt / Equity	0.26
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-34.84

Financial Efficiency

Return on equity (ROE) is -75.71% and return on invested capital (ROIC) is -42.77%.

Return on Equity (ROE)	-75.71%
Return on Assets (ROA)	-39.06%
Return on Invested Capital (ROIC)	-42.77%
Return on Capital Employed (ROCE)	-97.92%
Revenue Per Employee	n/a
Profits Per Employee	-$2.24M
Employee Count	61
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -51.62% in the last 52 weeks. The beta is 0.14, so ABOS's price volatility has been lower than the market average.

Beta (5Y)	0.14
52-Week Price Change	-51.62%
50-Day Moving Average	1.36
200-Day Moving Average	1.44
Relative Strength Index (RSI)	46.68
Average Volume (20 Days)	252,008

Short Selling Information

The latest short interest is 1.38 million, so 2.28% of the outstanding shares have been sold short.

Short Interest	1.38M
Short Previous Month	1.40M
Short % of Shares Out	2.28%
Short % of Float	4.19%
Short Ratio (days to cover)	2.93

Income Statement

Revenue	n/a
Gross Profit	-124.21M
Operating Income	-143.98M
Pretax Income	-55.94M
Net Income	-136.67M
EBITDA	-143.92M
EBIT	-143.98M
Earnings Per Share (EPS)	-$2.27

Balance Sheet

The company has $143.37 million in cash and $30.10 million in debt, giving a net cash position of $136.07 million or $2.25 per share.

Cash & Cash Equivalents	143.37M
Total Debt	30.10M
Net Cash	136.07M
Net Cash Per Share	$2.25
Equity (Book Value)	117.08M
Book Value Per Share	1.93
Working Capital	123.54M

Cash Flow

In the last 12 months, operating cash flow was -$117.76 million and capital expenditures -$88,000, giving a free cash flow of -$117.85 million.

Operating Cash Flow	-117.76M
Capital Expenditures	-88,000
Free Cash Flow	-117.85M
FCF Per Share	-$1.95

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ABOS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.87%
Shareholder Yield	-3.87%
Earnings Yield	-172.89%
FCF Yield	-149.09%

Analyst Forecast

The average price target for ABOS is $8.00, which is 488.24% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.00
Price Target Difference	488.24%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1